Ionis Pharmaceuticals Stock (NASDAQ: IONS) stock price, news, charts, stock research, profile.
Open | $44.87 |
Close | $45.60 |
Volume / Avg. | 1.07M / 1.22M |
Day Range | 44.35 - 45.85 |
52 Wk Range | 35.95 - 54.44 |
Market Cap | $6.66B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 7.02% |
Days to Cover | 9.25 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ionis Pharmaceuticals (NASDAQ:IONS) through any online brokerage.
Other companies in Ionis Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Cerevel Therapeutics Hldg (NASDAQ:CERE) and Roivant Sciences (NASDAQ:ROIV).
There is no analysis for Ionis Pharmaceuticals.
Ionis Pharmaceuticals has a consensus price target of $49.21.
The stock price for Ionis Pharmaceuticals (NASDAQ: IONS) is $45.6 last updated July 3, 2024 at 1:17 PM EDT.
There are no upcoming dividends for Ionis Pharmaceuticals.
Ionis Pharmaceuticals’s Q2 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Ionis Pharmaceuticals.
Ionis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.